AzTrials
AzTrials

Health Adult SubjectsNCT07468981

Movement Quality and Mechanical Properties of the Muscle

An observational study of Health Adult Subjects, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Movement quality is considered a comprehensive indicator of neuromuscular control, segmental stability, and efficient force transmission, and is recognized as an important determinant of musculoskeletal health and functional performance. Read more about this study

Who is it for?
Ages 18 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Health Adult Subjects
What is being tested?
Healthy Subjects
Type of treatment
Medical device
How many people
42 participants
Where
1 siteTurkey (Türkiye)
Study dates
7 Mar 2026to 15 Apr 2026
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: The research population consists of healthy individuals who do not have a regular exercise habit.

Who may be able to join

  • Female and male participants aged 18-40
  • Inactive individuals according to IPAQ Physical Activity Level
  • Individuals who volunteered to participate in the study

Who cannot join

  • Individuals who exercise and play sports regularly
  • Individuals with a history of surgery within the last 6 months
  • Individuals with active pain

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Faculty of Health Sciences

    Niğde, Bor

Other trials in Turkey (Türkiye)

About this study

Official title: Association Between Movement Quality and Passive Mechanical Properties of Skeletal Muscle in Healthy Adults

Movement quality is considered a comprehensive indicator of neuromuscular control, segmental stability, and efficient force transmission, and is recognized as an important determinant of musculoskeletal health and functional performance. Optimal movement patterns help distribute joint loading appropriately, whereas suboptimal movement strategies may contribute to increased biomechanical stress and the development of overuse injuries over time. In recent years, the passive mechanical properties of muscle (stiffness, tone, and elasticity) have been suggested to influence segmental stability and movement control; however, the relationship between these variables has not been sufficiently investigated in healthy populations. The aim of this study is to examine the association between movement quality and the passive mechanical properties of skeletal muscle in healthy adults.

Healthy adult individuals will be included in the study. The sample size was determined based on a priori power analysis, and a total of 42 participants will be recruited. Movement quality will be assessed using the Functional Movement Screen (FMS). The FMS is a standardized screening tool consisting of seven fundamental movement tasks designed to evaluate basic movement patterns. Each task will be scored on a scale from 0 to 3, and the total score (0-21 points) will be used as an indicator of overall movement quality. The passive mechanical properties of muscle (stiffness, tone, and elasticity) will be measured using a portable and non-invasive device, the MyotonPRO 5, from the quadriceps, hamstring, gastrocnemius, tibialis anterior, and erector spinae muscles. Measurements will be performed at standardized anatomical reference points with the muscle in a relaxed position. The device probe will be placed perpendicular to the skin surface over the muscle, and the passive viscoelastic response of the tissue will be recorded. The relationship between variables will be analyzed using Pearson or Spearman correlation analysis, depending on data distribution characteristics.

Being tested
Healthy Subjects

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Healthy SubjectsDevice

    The movement quality and passive mechanical properties of muscles will be evaluated in healthy participants.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Functional Movement Screen

    Movement quality will be assessed using FMS. There are a total of 7 subtests. These consist of basic movement patterns performed using body weight. Movement quality will be scored by the researchers. In the test, the minimum score is 0 and the maximum is 21, and an increase in the score reflects an increase in the quality of the movement.

    Measured: From enrollment to the end of evaluation at 4 weeks

Secondary outcomes (1)
  1. Muscle Viscoelasticity

    The passive mechanical properties of the muscle will be measured with the MyotonPro device. It is a non-invasive procedure. The device's probe is placed on the skin at a right angle, and the tissue's response is recorded by the device.

    Measured: rom enrollment to the end of assesment at 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Mar 2026
  2. Study start7 Mar 2026
  3. Primary completion15 Apr 2026
  4. Study completion15 Apr 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
42 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07468981
Sponsor's protocol ID
FMS
Status last verified
Jul 2026
First submitted
9 Mar 2026
Last updated
22 Jul 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Lee Y, Kim M, Lee H. The Measurement of Stiffness for Major Muscles with Shear Wave Elastography and Myoton: A Quantitative Analysis Study. Diagnostics (Basel). 2021 Mar 15;11(3):524. doi: 10.3390/diagnostics11030524.

    PubMed 33804273
  • Cook G, Burton L, Hoogenboom BJ, Voight M. Functional movement screening: the use of fundamental movements as an assessment of function - part 1. Int J Sports Phys Ther. 2014 May;9(3):396-409.

    PubMed 24944860
  • Kalkhoven JT, Watsford ML. The relationship between mechanical stiffness and athletic performance markers in sub-elite footballers. J Sports Sci. 2018 May;36(9):1022-1029. doi: 10.1080/02640414.2017.1349921. Epub 2017 Jul 12.

    PubMed 28697691

Questions about this trial

What is this clinical trial studying?

An observational study of Health Adult Subjects, run by Nigde Omer Halisdemir University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Functional Movement Screen (time frame: From enrollment to the end of evaluation at 4 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07468981, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in